PATENT CLAIM ANALYSIS

Application Number: 16192065
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "318000"]

Abstract:
A compound having the following formula: or a pharmaceutically acceptable salt thereof. A medicament or pharmaceutical composition contains the compound. A method of treating a respiratory tract disease includes administering to a patient an effective amount of a compound or a pharmaceutically acceptable salt thereof.

Claim (Index 15):
The method of  claim 14 , wherein the RNA-comprising virus is selected from the group consisting of rhinovirus, Coxsackie virus, and influenza virus.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.58065
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15718274', '15718226', '14783911', '15718295', '15718252']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972637257547046
- 35 USC 102 Novelty (BERT): 0.5890431681730753
- Combined Prediction Score: 0.7764416699965417
- Mean Citation Score: 472.319838
- Max Citation Score: 512.3073
- Similarity Product: 451.6247823200941

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test